Summarize with:
New Delhi: Corona vaccine development in near future in India? Trying to find answer to this, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India.
On the other hand, union health ministry claims that India continues to improve the Case Fatality Rate (CFR), and maintain its global position of having one of the lowest COVID fatalities rates.
With a further fall, the current CFR touched 2.11% today. This is the outcome of the well conceived and effectively implemented strategy of “Test, Track and Treat” which has guided the COVID management in the country.
Summarize with:
Discussion about this post